Dr. Pane is an active member of the steering committees of the Italian cooperative study Group GIMEMA, where he chairs the MPN working group, and of the European LeukemiaNet (ELN). His fruitful scientific activity has led to the publication of more than 310 peer-reviewed manuscripts in international medical journals already worth of more than 15,800 citations with a H score of 58. He currently serves as member of external reviewer commitees of clinical trials on the immune therapies with Gilead Science Inc. and Regeneron Inc. and is the chair of Data safety Monitoring Board of a Clinical Trial launched in 2022 by the Incyte Inc.
As Clinical Hematology Medical Director, Dr. Pane is responsible for overseeing daily operations of the Hematology healthcare facilities, reviewing healthcare laws and regulations to implement in daily practices, monitoring facility or department budgets and developing strategies to improve communication between medical professionals and patients.
Dr.Pane is past president of the Italian Society of Hematology (SIE – 2010 to 2017) and the Italian Society of Experimental Hematology (SIES – 2005 to 2006). He is currently president of the Italian Board of Professors of Hematology (2020 to date).